Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,620 | 1,117 | 99.6% |
| Education | $63.35 | 13 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,238 | 157 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,786 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,547 | 127 | $0 (2024) |
| ABBVIE INC. | $1,090 | 75 | $0 (2024) |
| Amgen Inc. | $1,059 | 67 | $0 (2024) |
| Allergan, Inc. | $821.82 | 67 | $0 (2020) |
| Lilly USA, LLC | $814.23 | 56 | $0 (2024) |
| PFIZER INC. | $597.52 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $590.46 | 44 | $0 (2023) |
| Merck Sharp & Dohme LLC | $503.28 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,854 | 108 | AstraZeneca Pharmaceuticals LP ($309.60) |
| 2023 | $1,858 | 116 | AstraZeneca Pharmaceuticals LP ($336.97) |
| 2022 | $1,862 | 126 | AstraZeneca Pharmaceuticals LP ($266.79) |
| 2021 | $1,986 | 136 | AbbVie Inc. ($341.64) |
| 2020 | $1,783 | 134 | GlaxoSmithKline, LLC. ($272.38) |
| 2019 | $1,720 | 143 | GlaxoSmithKline, LLC. ($226.87) |
| 2018 | $2,291 | 182 | GlaxoSmithKline, LLC. ($374.59) |
| 2017 | $2,331 | 185 | Allergan Inc. ($369.34) |
All Payment Transactions
1,130 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Biological | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: ADHD | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Biological | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: VACCINES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 3,831 | 7,886 | $613,327 | $212,708 |
| 2022 | 44 | 3,602 | 6,884 | $564,599 | $189,890 |
| 2021 | 56 | 4,329 | 7,066 | $577,123 | $308,078 |
| 2020 | 50 | 4,288 | 7,190 | $533,222 | $275,583 |
All Medicare Procedures & Services
195 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 674 | 1,702 | $229,770 | $72,425 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 482 | 1,079 | $102,505 | $42,727 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 611 | 611 | $82,485 | $26,577 | 32.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 120 | 158 | $8,670 | $6,307 | 72.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 65 | 65 | $11,700 | $6,063 | 51.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 68 | 79 | $22,910 | $5,157 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 62 | 92 | $8,740 | $5,091 | 58.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 38 | 38 | $6,610 | $4,868 | 73.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 262 | 542 | $13,550 | $4,803 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $8,640 | $4,569 | 52.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 103 | 246 | $8,590 | $3,950 | 46.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 95 | 115 | $10,120 | $2,583 | 25.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 39 | 57 | $8,875 | $2,357 | 26.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 31 | 36 | $7,740 | $2,162 | 27.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 44 | 54 | $4,050 | $2,005 | 49.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 17 | 17 | $6,766 | $1,939 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 34 | $6,460 | $1,735 | 26.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 17 | 19 | $2,622 | $1,592 | 60.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 42 | $1,890 | $1,435 | 75.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 31 | 50 | $6,250 | $1,398 | 22.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 16 | $2,500 | $1,315 | 52.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 42 | 45 | $3,870 | $1,137 | 29.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 34 | 38 | $2,470 | $1,091 | 44.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 14 | 14 | $3,640 | $946.68 | 26.0% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 35 | 44 | $2,200 | $936.32 | 42.6% |
About Dr. Darrin Menard, MD
Dr. Darrin Menard, MD is a Family Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417982422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darrin Menard, MD has received a total of $15,683 in payments from pharmaceutical and medical device companies, with $1,854 received in 2024. These payments were reported across 1,130 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,620).
As a Medicare-enrolled provider, Menard has provided services to 16,050 Medicare beneficiaries, totaling 29,026 services with total Medicare billing of $986,259. Data is available for 4 years (2020–2023), covering 195 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lafayette, LA
- Active Since 07/11/2006
- Last Updated 09/15/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417982422
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,318
- FARXIGA (Drug) $1,018
- Ozempic (Drug) $858.90
- VYVANSE (Drug) $541.07
- VRAYLAR (Drug) $493.52
- UBRELVY (Drug) $466.60
- Otezla (Drug) $449.50
- BREZTRI (Drug) $402.08
- QULIPTA (Drug) $355.29
- TRULICITY (Drug) $354.86
- XARELTO (Drug) $352.34
- BREO (Drug) $321.33
- MOUNJARO (Drug) $319.65
- Vascepa (Drug) $303.43
- XYOSTED (Drug) $284.47
- Victoza (Drug) $263.58
- LINZESS (Drug) $259.85
- TRINTELLIX (Drug) $256.01
- ANORO (Drug) $251.20
- Prolia (Biological) $243.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lafayette
Dr. Stephen Badylak, Dvm, Md, Phd, DVM, MD, PHD
Family Medicine — Payments: $1.8M
William Bray, M.d, M.D
Family Medicine — Payments: $167,020
Michael Iannotti, M.d, M.D
Family Medicine — Payments: $43,574
Dr. Matthew Abraham, M.d, M.D
Family Medicine — Payments: $23,305
Dr. Geoffrey Mire, Md, MD
Family Medicine — Payments: $15,244
Dr. James Mwatibo, Md, MD
Family Medicine — Payments: $10,984